Comparison of the Effect on Long-Term Outcomes in Patients With Thoracic Aortic Aneurysms of Taking Versus Not Taking a Statin Drug

Published:January 05, 2012DOI:
      The potential of medical therapy to influence the courses and outcomes of patients with thoracic aortic aneurysms is not known. The aim of this study was to determine whether statin intake is associated with improved long-term outcomes in these patients. A total of 649 patients with thoracic aortic aneurysms were studied, of whom 147 were taking statins at their first presentation and 502 were not. After a median follow-up period of 3.6 years, 30 patients (20%) taking statins had died, compared with 167 patients (33%) not taking statins (hazard ratio 0.68, 95% confidence interval 0.46 to 1, p = 0.049); 87 patients (59%) taking statins reached the composite end point of death, rupture, dissection, or repair compared with 378 patients (75%) not taking statins (hazard ratio 0.72, 95% confidence interval 0.57 to 0.91, p = 0.006). After adjustments for co-morbidities, the association between statin therapy and the composite end point was driven mainly by a reduction in aneurysm repairs (hazard ratio 0.57 95% confidence interval 0.4 to 0.83, p = 0.003). On Kaplan-Meier analysis, the survival rate of patients taking statins was significantly better (p = 0.047). In conclusion, the intake of stains was associated with an improvement in long-term outcomes in this cohort of patients with thoracic aortic aneurysms. This was driven mainly by a reduction in aneurysm repairs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Thom T.
        • Haase N.
        • Rosamond W.
        • Howard V.J.
        • Rumsfeld J.
        • Manolio T.
        • Zheng Z.J.
        • Flegal K.
        • O'Donnell C.
        • Kittner S.
        • Lloyd-Jones D.
        • Goff Jr, D.C.
        • Hong Y.
        • Adams R.
        • Friday G.
        • Furie K.
        • Gorelick P.
        • Kissela B.
        • Marler J.
        • Meigs J.
        • Roger V.
        • Sidney S.
        • Sorlie P.
        • Steinberger J.
        • Wasserthiel-Smoller S.
        • Wilson M.
        • Wolf P.
        Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
        Circulation. 2006; 113: e85-e151
        • Isselbacher E.M.
        Thoracic and abdominal aortic aneurysms.
        Circulation. 2005; 111: 816-828
        • Smeeth L.
        • Douglas I.
        • Hall A.J.
        • Hubbard R.
        • Evans S.
        Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.
        Br J Clin Pharmacol. 2009; 67: 99-109
        • Koullias G.J.
        • Ravichandran P.
        • Korkolis D.P.
        • Rimm D.L.
        • Elefteriades J.A.
        Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
        Ann Thorac Surg. 2004; 78: 2106-2110
        • Danyi P.
        • Elefteriades J.A.
        • Jovin I.S.
        Medical therapy of thoracic aortic aneurysms: are we there yet?.
        Circulation. 2011; 124: 1469-1476
        • Guessous I.
        • Periard D.
        • Lorenzetti D.
        • Cornuz J.
        • Ghali W.A.
        The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis.
        PLoS One. 2008; 3: e1895
        • Hackam D.G.
        • Thiruchelvam D.
        • Redelmeier D.A.
        Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.
        Lancet. 2006; 368: 659-665
        • Coady M.A.
        • Rizzo J.A.
        • Hammond G.L.
        • Kopf G.S.
        • Elefteriades J.A.
        Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications.
        Ann Thorac Surg. 1999; 67: 1922-1926
        • Elefteriades J.A.
        Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks.
        Ann Thorac Surg. 2002; 74: S1877-S1880
        • Coady M.A.
        • Ikonomidis J.S.
        • Cheung A.T.
        • Matsumoto A.H.
        • Dake M.D.
        • Chaikof E.L.
        • Cambria R.P.
        • Mora-Mangano C.T.
        • Sundt T.M.
        • Sellke F.W.
        Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association.
        Circulation. 2010; 121: 2780-2804
        • Davies R.R.
        • Gallo A.
        • Coady M.A.
        • Tellides G.
        • Botta D.M.
        • Burke B.
        • Coe M.P.
        • Kopf G.S.
        • Elefteriades J.A.
        Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms.
        Ann Thorac Surg. 2006; 81: 169-177
        • Rubin D.B.
        Estimating causal effects from large data sets using propensity scores.
        Ann Intern Med. 1997; 127: 757-763
        • Rizzo J.A.
        • Coady M.A.
        • Elefteriades J.A.
        Procedures for estimating growth rates in thoracic aortic aneurysms.
        J Clin Epidemiol. 1998; 51: 747-754
        • Weissberg P.
        Mechanisms modifying atherosclerotic disease—from lipids to vascular biology.
        Atherosclerosis. 1999; 147: S3-S10
        • Mosorin M.
        • Niemela E.
        • Heikkinen J.
        • Lahtinen J.
        • Tiozzo V.
        • Satta J.
        • Juvonen T.
        • Biancari F.
        The use of statins and fate of small abdominal aortic aneurysms.
        Interact Cardiovasc Thorac Surg. 2008; 7: 578-581
      1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
        Lancet. 2002; 360: 7-22
        • Genoni M.
        • Paul M.
        • Jenni R.
        • Graves K.
        • Seifert B.
        • Turina M.
        Chronic beta-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection.
        Eur J Cardiothorac Surg. 2001; 19: 606-610
        • Brooke B.S.
        • Habashi J.P.
        • Judge D.P.
        • Patel N.
        • Loeys B.
        • Dietz III, H.C.
        Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
        N Engl J Med. 2008; 358: 2787-2795